OpenFilings

Neuphoria Therapeutics Inc.

Form8-K

Report Period2024-12-23

Date Filed2024-12-23

Time Filed17:14:50

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

CURRENT REPORT
SCHEME IMPLEMENTATION AGREEMENT, DATED OCTOBER 1, 2024, BETWEEN BIONOMICS LIMITE
AMENDING AGREEMENT TO SCHEME IMPLEMENTATION AGREEMENT, DATED OCTOBER 24, 2024, B
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS FILED WITH THE SECRETARY O
BYLAWS, DATED AUGUST 2, 2024
FORM OF INDEMNIFICATION AGREEMENT
NEUPHORIA THERAPEUTICS INC. 2024 EQUITY INCENTIVE PLAN
CODE OF CONDUCT
DESCRIPTION OF CAPITAL STOCK
PRESS RELEASE, DATED DECEMBER 23, 2024
Filing on SEC Edgar